In today’s session Dow Chemical Co (DOW) recorded an unusually high (292) contracts volume of put trades. Someone, most probably a professional was a very active buyer of the October, 2016 put, expecting serious DOW decrease. With 292 contracts traded and 26034 open interest for the Oct, 16 contract, it seems this is a quite bearish bet. The option with symbol: DOW161021P00052500 closed last at: $1.3 or 8.5% down. The stock decreased 1.07% or $0.56 during the last trading session, hitting $51.86. About 6.87 million shares traded hands or 16.05% up from the average. Dow Chemical Co (NYSE:DOW) has risen 4.69% since March 1, 2016 and is uptrending. It has underperformed by 4.55% the S&P500.
Analysts await Dow Chemical Co (NYSE:DOW) to report earnings on October, 27 before the open. They expect $0.77 earnings per share, down 6.10% or $0.05 from last year’s $0.82 per share. DOW’s profit will be $877.50M for 16.84 P/E if the $0.77 EPS becomes a reality. After $0.95 actual earnings per share reported by Dow Chemical Co for the previous quarter, Wall Street now forecasts -18.95% negative EPS growth.
Dow Chemical Co (NYSE:DOW) Ratings Coverage
Out of 13 analysts covering The Dow Chemical Company (NYSE:DOW), 7 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 54% are positive. $65 is the highest target while $45 is the lowest. The $56.58 average target is 9.10% above today’s ($51.86) stock price. The Dow Chemical Company has been the topic of 32 analyst reports since August 20, 2015 according to StockzIntelligence Inc. The company was maintained on Monday, May 2 by Jefferies. The firm has “Outperform” rating given on Friday, September 11 by Bernstein. The firm earned “Hold” rating on Monday, December 14 by Jefferies. The firm has “Outperform” rating given on Friday, April 29 by RBC Capital Markets. The firm earned “Buy” rating on Friday, October 23 by Deutsche Bank. The firm earned “Neutral” rating on Tuesday, June 28 by JP Morgan. The firm has “Outperform” rating by Credit Suisse given on Thursday, March 24. Susquehanna upgraded the stock to “Positive” rating in Monday, February 8 report. The company was maintained on Thursday, August 20 by Deutsche Bank. The rating was maintained by Citigroup on Monday, April 18 with “Neutral”.
Insitutional Activity: The institutional sentiment decreased to 1.16 in Q2 2016. Its down 0.09, from 1.25 in 2016Q1. The ratio worsened, as 60 funds sold all Dow Chemical Co shares owned while 354 reduced positions. 70 funds bought stakes while 410 increased positions. They now own 734.11 million shares or 6.94% less from 788.82 million shares in 2016Q1.
Cullinan Associate Inc holds 0.05% of its portfolio in Dow Chemical Co (NYSE:DOW) for 13,300 shares. Concorde Asset Management Lc reported 5,159 shares or 0.25% of all its holdings. Cleararc Cap owns 27,293 shares or 0.26% of their US portfolio. Moreover, Parkside Savings Bank And Trust has 0.12% invested in Dow Chemical Co (NYSE:DOW) for 4,760 shares. Asset Mgmt Of Georgia Inc Ga Adv holds 0.94% or 24,292 shares in its portfolio. Tiemann Inv Advsrs Limited Liability Corporation last reported 0.21% of its portfolio in the stock. Iowa National Bank & Trust holds 0.03% of its portfolio in Dow Chemical Co (NYSE:DOW) for 1,412 shares. Guardian Mngmt holds 30,000 shares or 1.66% of its portfolio. First Midwest Comml Bank Tru Division accumulated 0.03% or 4,224 shares. Century accumulated 0.29% or 5.16M shares. Alps Advsrs Inc accumulated 501,377 shares or 0.22% of the stock. Shoker Invest Counsel owns 29,640 shares or 1.31% of their US portfolio. Moreover, First Tru Advsr L P has 0.11% invested in Dow Chemical Co (NYSE:DOW) for 726,259 shares. Babson Capital Mngmt Limited Liability has 101,576 shares for 0.13% of their US portfolio. Whittier Trust Of Nevada last reported 0.15% of its portfolio in the stock.
The Dow Chemical Company is a maker and supplier of products used primarily as raw materials in the manufacture of customer services and products across the world. The company has a market cap of $59.10 billion.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.